These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16651359)

  • 21. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 22. Patent ductus arteriosus in the preterm infant.
    Kirsten D
    Neonatal Netw; 1996 Mar; 15(2):19-26. PubMed ID: 8700090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.
    Godambe S; Newby B; Shah V; Shah PS
    Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The problem of ductal patency in prematures.
    O'Loughlin JE
    Pediatr Ann; 1981 Apr; 10(4):39-46. PubMed ID: 7015261
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of the premature infant with a patent ductus arteriosus.
    Dooley KJ
    Pediatr Clin North Am; 1984 Dec; 31(6):1159-74. PubMed ID: 6504592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In partial defense of prolonged indomethacin therapy for patent ductus arteriosus.
    Hammerman C
    J Pediatr; 2000 May; 136(5):707-8. PubMed ID: 10802512
    [No Abstract]   [Full Text] [Related]  

  • 28. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
    Hammerman C
    Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin therapy for patent ductus arteriosus in premature infants.
    Lee KS
    Pediatr Cardiol; 2008 Sep; 29(5):873-5. PubMed ID: 18401636
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
    Gersony WM; Peckham GJ; Ellison RC; Miettinen OS; Nadas AS
    J Pediatr; 1983 Jun; 102(6):895-906. PubMed ID: 6343572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Closure of the ductus arteriosus by medication in low birth weight infants].
    Polgár M; Kemény J; Szirmai Z
    Orv Hetil; 1979 Oct; 120(43):2613-4. PubMed ID: 545236
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined noninvasive assessment of the patent ductus arteriosus in the preterm infant before and after indomethacin treatment.
    Smallhorn JF; Gow R; Olley PM; Freedom RM; Swyer PR; Perlman M; Rowe RD
    Am J Cardiol; 1984 Dec; 54(10):1300-4. PubMed ID: 6507302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indomethacin for patent ductus arteriosus.
    Med Lett Drugs Ther; 1981 Oct; 23(22):95-6. PubMed ID: 7289976
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of indomethacin in the closure of patent ductus arteriosus in premature newborn infants with cardiac insufficiency. Analysis of 14 cases].
    Atik E; Moromizato JH; Zan R; Ajzenberg M; Esher R; Diniz EM; Souza AT; Martins CO; Bastos JC
    Arq Bras Cardiol; 1984 Sep; 43(3):185-9. PubMed ID: 6535546
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.
    Walters M
    BMJ; 1988 Sep; 297(6651):773-4. PubMed ID: 3142543
    [No Abstract]   [Full Text] [Related]  

  • 36. Should a prolonged or short course of indomethacin be used in preterm infants to treat patent ductus arteriosus?
    Shah S
    Arch Dis Child; 2003 Dec; 88(12):1132-3. PubMed ID: 14670791
    [No Abstract]   [Full Text] [Related]  

  • 37. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
    Attridge JT; Kaufman DA; Lim DS
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of patent ductus arteriosus.
    Friedman WF
    Adv Cardiol; 1979; 26():65-75. PubMed ID: 420062
    [No Abstract]   [Full Text] [Related]  

  • 39. Global shortage and rationing of indomethacin: need to refine approach.
    Sehgal A
    J Perinatol; 2010 Jun; 30(6):384-7. PubMed ID: 20508630
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.
    Clyman RI
    J Pediatr; 1996 May; 128(5 Pt 1):601-7. PubMed ID: 8627430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.